Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 9/20 | 0.46 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3916488 | 0.83 | FOLH1 (0.50) | CLCN2KDM4EMAPK1HPGDHSD17B10 | |
| SCHEMBL506923 | 0.81 | SMN1; SMN2 (0.46) | KDM4EMAPK1 | |
| SCHEMBL2972991 | 0.80 | MEP1B (0.48) | KDM4EHPGD | |
| SCHEMBL4238088 | 0.79 | KAT6A (0.54) | MRGPRX4CLCN2KDM4EKAT6AALB | |
| SCHEMBL27984139 | 0.79 | KDM4E (0.43) | KDM4EMAPK1 | |
| SCHEMBL31284578 | 0.79 | KDM4E (0.43) | KDM4EMAPK1 | |
| SCHEMBL18261999 | 0.79 | KDM4E (0.43) | KDM4E | |
| SCHEMBL27714282 | 0.79 | SMN1; SMN2 (0.50) | KDM4EMAPK1HPGD | |
| SCHEMBL30701130 | 0.77 | ALDH1A1 (0.48) | MRGPRX4CLCN2KAT6AMAPK1ALB | |
| SCHEMBL31645683 | 0.76 | P2RX7 (0.47) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059562-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |